{
  "ticker": "DD",
  "content": "**Report Generated:** January 22, 2026  \n**Next Refresh:** April 23, 2026\n\n**Disclaimer:** This sell-side report was generated using Claude Sonnet 4 (claude-sonnet-4-20250514). Please confirm all critical data independently, as AI models may hallucinate. These reports are for educational purposes only, and should not be solely used for investment decisions.\n\n---\n\n# DuPont de Nemours, Inc. (DD) - Comprehensive Analysis Report\n\n## 1. Company Overview\n\nDuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. With a legacy stretching back to 1802, and a $12.39 billion in revenue for 2024, DuPont has evolved into a leader, providing technology-based materials and solutions.\n\nFollowing a significant corporate transformation, the company has completed a major restructuring. DuPont (NYSE: DD) announced that it completed the separation of its electronics business into an independent public company, Qnity Electronics, Inc. (\"Qnity\"), on November 1, 2025. The spin-off will leave DuPont with 13,000 employees across 19 global research and development centers.\n\nIt operates through two segments, ElectronicsCo and IndustrialsCo. Post-transformation, the new DuPont is focused on two main business segments: Healthcare & Water Technologies and Diversified Industrials, serving critical markets including healthcare, water treatment, construction, automotive, and aerospace industries.\n\n## 2. Current Market Data\n\nThe Dupont De Nemours Inc stock price today is 42.86. Previous Close · 42.28 · Open · 42.87 · Bid 43.31 x 20000 · Ask 43.33 x 30000 · Day's Range · 42.68 - 43.59 · 52 Week Range · 22.50 - 44.17 · Volume · 1,964,845 · Avg. Volume · 6,238,551 · Market Cap (intraday) 18.137B · Beta (5Y Monthly) 1.11 · PE Ratio (TTM) 25.02 · EPS (TTM) 1.73 · Earnings Date Feb 10, 2026 · Forward Dividend & Yield 1.43 (3.38%) Ex-Dividend Date Nov 28, 2025 · 1y Target Est · 49.00\n\nRecent board appointment: DuPont announced the appointment of D.G. Macpherson to its Board of Directors effective immediately on January 20, 2026.\n\n## 3. Existing Products/Services\n\nDuPont's product portfolio spans multiple high-performance material categories:\n\n**Healthcare & Water Technologies:**\n- The health care division brought in $1.7 billion in net sales with 90% of the top medical companies using DuPont's medical devices, packaging, personal protective equipment and biopharma products.\n- DuPont's water division is 25% of its business with products in ultrafiltration, membrane bioreactors, nanofiltration, and ion exchange technology.\n\n**Diversified Industrials:**\n- DuPont's diversified industrials is a $3.6 billion division that has 50% of its sales in construction with leading brands like Tyvek and ArmorWall but also is deeply embedded with electric vehicle and aerospace manufacturers as well as those in packaging.\n- DuPont developed many polymers such as Vespel, neoprene, nylon, Corian, Teflon, Mylar, Kapton, Kevlar, Zemdrain, M5 fiber, Nomex, Tyvek, Sorona, viton, Corfam and Lycra in the 20th century\n\n## 4. Planned Products/Services/Projects\n\n**Product Innovation:**\nDuPont (NYSE:DD) today unveiled Ty... and Kevlar® EXO™ expansion news on Dec 5, 2025 saw a 1.73% gain, showing better reception for growth-oriented product updates\n\n**Capacity Expansion:**\nPriority pipeline actions include capacity debottlenecks for electronics materials to support AI and HBM packaging ramps (2025–2027), incremental membrane capacity tied to awarded desal projects, and medical-device line expansions from the Spectrum Plastics platform.\n\n## 5. Growth Strategy\n\nNew DuPont: A Focused, High Performing Company with a Clear Strategy to Accelerate Value Creation · Executing Transformation: The new DuPont is a simplified portfolio, increasingly focused on high growth end markets with secular tailwinds with further opportunity to optimize. \"We have a clear path to our 2028 financial targets which includes solid revenue and earnings growth along with robust cash generation. Our strong balance sheet positions us to invest for the future while also allowing us to continue to return cash to shareholders.\n\n**Medium-Term Financial Targets (2026-2028):**\nThe company has established medium-term targets for 2026-2028, including 3-4% organic sales CAGR, 150-200 basis points of margin expansion, 8-10% EPS CAGR, and free cash flow conversion exceeding 90%.\n\n**Strategic Focus Areas:**\nManagement targets mid-single-digit organic growth through the cycle, driven by electronics, water, and safety end-markets and by prioritizing advantaged technologies. Strategy emphasizes margin expansion via portfolio mix toward specialties and continuous productivity programs\n\n## 6. Current and Potential Major Clients\n\nDuPont serves a diverse range of industries with major clients including:\n\n**Healthcare:** 90% of the top medical companies using DuPont's medical devices, packaging, personal protective equipment and biopharma products\n\n**Industry Segments Served:**\nThe Company's segments collectively serve customers across the following sectors: Agriculture, including crop producers, and farming businesses; Automotive, including automotive manufacturers and aftermarket service providers; Building and Construction, including construction firms, specialist contractors, property development companies, and infrastructure development companies; Electronics, including consumer electronics manufacturers and photovoltaic product manufacturers; Energy, including energy producers, oil and gas companies, and power transmission companies; Food and Beverage, including food and beverage producers and marketers; Government and Public Sector; Health and Medical, including healthcare providers, medical device manufacturers, and medical supply and packaging companies\n\n**Partnership Examples:**\n\"The partnership with TecWater and DuPont has resulted in a great volume of high-quality water.\" Carlos Alberto de Arruda, Head of the Várzea Grande Water & Sewerage Department\n\n## 7. Financial Data & Performance\n\n**Q3 2025 Results:**\nDuPont de Nemours Inc (NYSE:DD) reported a solid third quarter with sales of $3.1 billion, reflecting a 6% organic growth. Operating EBITDA increased by 6% year-over-year to $840 million, resulting in a strong operating EBITDA margin of 27.3%.\n\nThe company announced a new quarterly dividend of $0.20 per share and a $2 billion share repurchase authorization, demonstrating a commitment to disciplined capital allocation.\n\n**Guidance Updates:**\nDuPont raised its full-year 2025 operating EBITDA guidance from $1.575 billion to $1.6 billion, citing stronger business results and accelerating corporate cost reductions.\n\n**Pro Forma 2025 Outlook:**\nDuPont has revised its financial outlook, lowering its net sales estimate to $6.85 billion for the new DuPont entity post-separations.\n\n## 8. Headwinds & Tailwinds\n\n**Tailwinds:**\n- The company is seeing strong demand in its electronics segment, driven by AI technology, and expects continued growth in health care and water technologies.\n- There's a $3 billion addressable market in industrial water use and potential growth in PFAS clean-up and green hydrogen.\n- Healthcare & Water Technologies sales up high-single digits on strong organic growth with increases in both businesses. Volume gains were driven by growth for medical packaging and biopharma and continued strength in reverse osmosis and ion exchange.\n\n**Headwinds:**\n- One risk is the decline in residential spending in U.S. construction, which is expected to continue due to high interest and mortgage rates.\n- While the company faces some near-term challenges from semiconductor shortages and supply-chain disruptions\n- Diversified Industrials sales up low-single digits on an organic basis, as growth in Industrial Technologies was partially offset by continued softness in construction\n\n## 9. Market Shares\n\nIn 2022, DuPont held a market share of 3.85% in the materials sector, which reflects its position as a significant player in the industry. DuPont's market capitalization stands at $33 billion, which is smaller than that of the top 10 chemicals companies, whose market caps range from $163 billion to $41 billion.\n\nMarket positioning varies by segment, with stronger positions in specialized areas like protective materials and water treatment technologies where DuPont commands premium pricing.\n\n## 10. Comparison to Competitors\n\n**Key Competitors:**\nCompetitors of DuPont include Wilbur-Ellis Company, Intrinsyx Bio, INEOS, Stanmore Resources, Circa Group and 7 more. Dow and Parker-Hannifin are competitors of DuPont de Nemours.\n\n**Competitive Position:**\nCommands premium pricing in electronics and protection sectors. Trails larger, diversified conglomerates like BASF in overall scale. Faces margin pressure in commoditized polymer segments.\n\nDuPont de Nemours operates within a highly fragmented competitive landscape defined by its diversified specialty chemicals portfolio. The company faces distinct rivals in each of its core market segments, ranging from Japanese electronics giants to European chemical conglomerates and agile startups. This competitive environment demands continuous innovation and strategic positioning to maintain its market leadership established throughout its long history.\n\n## 11. Partnerships, Mergers and Acquisitions\n\n**Recent M&A Activity:**\nDuPont acquired Donatelle Plastics and SpectrumPlastics in the last two years, which Koch touted as examples of DuPont's \"sweet spot\" of acquiring companies to boost its value in the market.\n\n**Future M&A Strategy:**\nKoch added that DuPont has a \"robust pipeline of targets and is actively scouting new opportunities\" at this time.\n\n**Major Divestitures:**\nOn August 29, 2025, DuPont announced a definitive agreement to sell the aramids business (the \"Aramids Divestiture\") to TJC LP, (\"TJC\"), in return for cash proceeds of approximately $1.2 billion, subject to customary transaction adjustments, a note from TJC in the principal amount of $300 million and a minority equity interest valued at $325 million\n\n## 12. Recent Developments\n\n**Major Corporate Actions (November 2025 - January 2026):**\n\n- **November 1, 2025:** DuPont completed the separation of its electronics business into an independent public company, Qnity Electronics, Inc.\n\n- **November 6, 2025:** Q3 2025 earnings announced with strong performance\n\n- **January 20, 2026:** DuPont announced the appointment of D.G. Macpherson to its Board of Directors effective immediately\n\n- **January 21, 2026:** DuPont (NYSE: DD) will release its fourth quarter and full year 2025 financial results at 6:00 a.m. ET on Tuesday, February 10, 2026.\n\n**Upcoming Transactions:**\nThe transaction is expected to close in the first quarter 2026, subject to customary closing conditions and receipt of regulatory approvals. (referring to the Aramids divestiture)\n\n## 13. AI Investment Rating & Fair Value Assessment\n\n**Investment Strengths:**\n- Strong transformation execution with successful Qnity separation\n- Focused portfolio on high-growth, high-margin segments (healthcare, water, protection)\n- Strong financial performance with 6% organic growth and improving margins\n- Robust cash generation supporting $2B share buyback and dividend initiation\n- Strategic positioning in secular growth markets (AI, healthcare, water scarcity)\n- Strong medium-term targets: 3-4% organic sales CAGR, 8-10% EPS CAGR through 2028\n\n**Investment Concerns:**\n- Construction market weakness affecting Diversified Industrials segment\n- Stock trading well below 52-week highs despite strong fundamentals\n- Execution risk on medium-term targets amid macroeconomic uncertainty\n- Legacy PFAS liabilities remain an overhang\n\n**Valuation Analysis:**\nWith the current stock price of approximately $42.86 and analyst target estimates around $48.44 average 12-month price target, the stock appears undervalued relative to its transformation potential and strong operational execution.\n\nBased on the successful portfolio transformation, strong cash generation, exposure to secular growth trends, and conservative management guidance achieving medium-term targets, along with current trading multiples below historical averages for a focused specialty chemicals leader:\n\n**Buy Rating: 8.2/10**\n\n**Estimated Fair Value: $58-62 per share**\n\nThis represents approximately 35-45% upside from current levels, supported by:\n- Multiple expansion as transformation story becomes clearer\n- Execution on medium-term financial targets\n- Strong free cash flow generation supporting capital returns\n- Premium valuation warranted for focused, higher-growth portfolio\n- Recovery in construction markets providing additional upside\n\nThe rating reflects strong conviction in management's execution capability, attractive risk-adjusted returns for growth-oriented investors with moderate risk appetite, while acknowledging near-term headwinds in certain end markets.",
  "generated_date": "2026-01-22T07:49:38.090773",
  "next_refresh_date": "2026-04-23T07:49:38.090773",
  "model": "claude-sonnet-4-20250514",
  "cost": 0.39482639999999997,
  "tokens": {
    "input": 188,
    "output": 4364,
    "cache_creation": 69104,
    "cache_read": 232208
  },
  "tldr_summary": "DuPont de Nemours is a technology-driven materials and solutions company serving healthcare, water treatment, construction, automotive, and aerospace industries, with $12.39 billion in 2024 revenue. Following a strategic transformation, the company has divested its electronics business and now focuses on two core segments: Healthcare & Water Technologies and Diversified Industrials, with strong market positions in medical devices, protective equipment, water treatment technologies, and specialty materials.\n\nThe company demonstrates robust growth potential through targeted investments in high-performance markets, aiming for 3-4% organic sales CAGR and 8-10% EPS growth by 2028. Key strengths include innovative product lines like Tyvek and Kevlar, strategic partnerships across multiple industries, and a disciplined approach to portfolio optimization. Recent developments include a successful electronics business spin-off and targeted acquisitions in specialty plastics.\n\nWith a buy rating of 8.2/10 and an estimated fair value of $58-62 per share, DuPont offers attractive upside potential driven by strategic transformation and exposure to secular growth markets."
}